Jasper Therapeutics
JSPR----
Jasper Therapeutics (JSPR)
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United Sta...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Jasper Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 2, 2026Price forecast
$9.171170.50%
Forecast & RatingBuy
5analysts
- Strong buy20.00%
- Buy20.00%
- Hold60.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 8 hours ago
Capital Allocation Signals: Mid-Cap Firms Pivot to Strategic Consolidation
- Price Alert · 17 hours ago
U.S. stock night trading volatility: Jasper Therapeutics fell 3% in after-hours trading, with executives disclosing their holdings intensively attracting attention
- PUBT · 21 hours ago
Jasper Therapeutics names Greg Keenan as chief medical officer in initial beneficial ownership filing
- Price Alert · 1 day ago, 11:46 PM
U.S. stock night trading volatility: Jasper Therapeutics fell 3.93% in after-hours trading, with executive sell-offs and positive cooperation failing to mask market concerns
- PUBT · 1 day ago, 06:11 PM
Jasper Therapeutics COO Matthew E. Ros files initial beneficial ownership statement
- Global Report · 2 days ago, 04:17 AM
Chime's Expansion and Jasper's M&A Deal Highlight Micro-Catalyst Driven US Market
